|
Olink Holding Ab publ (NASDAQ: OLK) |
|
|
|
|
Select the Financial Report:
|
|
Select the Period:
|
|
Description of Olink Holding Ab Publ's Business Segments
Olink Holding Ab publ is a Swedish biotechnology company that specializes in the development and provision of innovative products and services aimed at biomarker discovery and validation, playing a significant role in advancing scientific research and clinical applications. The company operates through two primary segments: Olink Explore and Olink Proteomics, each focusing on distinct but complementary aspects of biomarker research.
Olink Explore
The Olink Explore segment is dedicated to the creation of protein biomarker panels that serve primarily research applications. Leveraging its proprietary Proximity Extension Assay (PEA) technology, Olink Explore offers researchers a highly sensitive and high-throughput approach to discover new protein biomarkers. This technology allows for the simultaneous measurement of multiple proteins from a variety of sample types, including blood, tissue, and cells, enabling researchers to conduct extensive studies without the need for large sample volumes.
Key Features of Olink Explore:
1. Extensive Biomarker Panels: Olink Explore provides an extensive catalog of over 1,400 ready-to-use biomarker panels that cover multiple research areas, such as:
- Oncology: Biomarkers relevant to various cancer types, aiding in the understanding of tumor biology and therapeutic targets.
- Neurology: Panels focused on neurological disorders, exploring biomarkers linked to Alzheimers disease, multiple sclerosis, and other conditions.
- Cardio-Metabolic Disease: Panels aimed at understanding markers linked to cardiovascular health and metabolic syndromes.
- Inflammation: Biomarker panels that investigate inflammatory pathways, contributing to research in autoimmune diseases and chronic inflammation.
2. Custom Biomarker Development: In addition to ready-to-use panels, Olink Explore offers custom biomarker panels tailored to specific research needs, allowing scientists to focus on particular proteins of interest relevant to their studies.
3. Olink Explore Services: This includes data analysis, validation, and comprehensive support to researchers, ensuring that the biomarker data generated is interpretable and robust for their specific applications.
4. Reagents and Instruments: Olink Explore supplies the necessary reagents and instruments required for conducting PEA, providing a comprehensive toolkit for scientists.
Olink Proteomics
The Olink Proteomics segment is focused on developing solutions aimed at targeted protein analysis in clinical research and diagnostics. Here, the advanced PEA technology is leveraged for measuring multiple proteins with exceptional sensitivity and specificity, even from limited or difficult-to-obtain sample types, such as dried blood spots.
Key Offerings of Olink Proteomics:
1. Olink Oncology Test: This diagnostic tool allows the measurement of 845 protein biomarkers specifically curated for cancer research, assisting in the evaluation and stratification of tumors based on protein expression profiles, which can lead to personalized treatment strategies.
2. Olink COVID-19 Test: In response to the global pandemic, Olink developed this test to measure 1,920 protein biomarkers associated with COVID-19, facilitating research into the disease pathophysiology, vaccine development, and immune response analytics.
3. Olink Target Selector PCR: This product line enables targeted gene expression analysis, complementing the proteomic data with genetic insights that can further aid in understanding disease mechanisms and therapeutic responses.
Strategic Commitments
Olink Holding Ab publ is deeply committed to enhancing human health through its innovative biomarker discovery and validation solutions. The companys technology platforms and product offerings significantly contribute to early diagnosis, personalized treatment approaches, and drug development, thereby addressing critical needs in healthcare and advancing the frontiers of biomedical research.
By providing accessible and reliable tools for both researchers and clinicians, Olink is poised to make a lasting impact on various fields of medicine and science, positioning itself as a key player in the biotechnology landscape focused on improving patient outcomes through advanced biomarker insights.
|
|
